Back
HFA Premium Access

Risk factors for heart failure after epirubicin chemotherapy for breast or colorectal cancer

Session: Poster session 3 - Comorbodities
Topic: Cancer/Cardiotoxicity
Speaker: Doctor G. Fogarassy (Balatonfured, HU)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speaker

Doctor Gyorgy Fogarassy

Balatonfured State Cardiology Hospital, Balatonfured (Hungary)
0 follower

29 more presentations in this session

Chemotherapy-induced cardiotoxicity in a Colombian heart failure program

Speaker: Professor C. Saldarriaga Giraldo (Medellin, CO)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular monitoring and management in cancer patients: a french national survey

Access
Like
Thumbnail

Subgroups analyses of a prospective long-term study in patients with advanced cancer - the prognostic impact of elevated heart rate.

Speaker: Doctor M. Anker (Berlin, DE)

Access
Abstract
Like
Thumbnail

The cumulative effect of chemoradiotherapy in the risk of developing cardiotoxicity

Speaker: Doctor A. Gomes (Almada, PT)

Access
Abstract
Like
Thumbnail

Improving ventricular function in patients with severe ventricular dysfunction previous to kidney transplantation.

Speaker: Doctor C. Martinez Hernandez (San Luis Potosi, MX)

Access
Like
Thumbnail

Access the full session

Poster session 3 - Comorbodities

Speakers: Doctor G. Fogarassy, Professor C. Saldarriaga Giraldo, Doctor M. Anker, Doctor A. Gomes, Doctor C. Martinez Hernandez
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources